Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001171843-22-004516

Options or other derivatives

  • COO, US acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kottayil George COO, US 2022-06-22 Grant or award · 06/22/2022 +50,000 50,000 D
Loading xslF345X03/ownership.xml…